Ā | BI with metformin | BI without metformin |
---|---|---|
Full population initiating BI therapy ( N = 12,358) | N = 6621 (53.6ā%) | N = 5737 (46.4ā%) |
Ā OAD number per day at visit 3 | 1.63 Ā± 0.76 | 1.19 Ā± 0.74 |
Ā Metformin (%) | 85.9ā% | 16.1ā% |
Ā Sulfonylureas (%) | 30.3ā% | 27.8ā% |
Ā Glinides (%) | 18.3ā% | 28.6ā% |
Ā Ī±-glycosidase inhibitors (%) | 23.5ā% | 45.3ā% |
Ā BI dose at visit3 (U/day/kg) | 0.16 Ā± 0.12 | 0.18 Ā± 0.11 |
Ā Insulin dose at visit3 (U/kg/day) | 0.18 Ā± 0.13 | 0.20 Ā± 0.13 |
Ā Staple food at visit3 (g) | 161.16 Ā± 44.02 | 156.15 Ā± 42.69 |
Ā Vegetables at visit3 (g) | 188.08 Ā± 66.49 | 184.61 Ā± 64.72 |
Ā Fruit at visit3 (g) | 100.17 Ā± 42.76 | 98.62 Ā± 39.86 |
Ā Meat at visit3 (g) | 104.94 Ā± 37.26 | 103.09 Ā± 35.21 |
Ā Days of participating in >30Ā min physical activity in past 7 days at visit3 | 5.98 Ā± 1.99 | 5.86 Ā± 2.09 |
Ā Days of participating in specific exercise session in past 7 days at visit3 | 4.11 Ā± 2.91 | 4.00 Ā± 2.90 |
Sub-population keeping BI therapy during 6-month follow-up ( NĀ = 8068) | N = 4269 (52.9ā%) | N = 3799 (47.1ā%) |
Ā OAD number per day at visit 3 | 1.75 Ā± 0.65 | 1.08 Ā± 0.66 |
Ā Sulfonylureas (%) | 32.1ā% | 28.1ā% |
Ā Glinides (%) | 17.8ā% | 28.6ā% |
Ā Ī±-glycosidase inhibitors (%) | 21.6ā% | 46.1ā% |
Ā BI dose at visit 3 (U/day/kg) | 0.21 Ā± 0.09 | 0.21 Ā± 0.09 |
Ā Staple food at visit 3 (g) | 161.37 Ā± 43.61 | 154.81 Ā± 41.17 |
Ā Vegetables at visit 3 (g) | 185.73 Ā± 65.28 | 180.62 Ā± 63.87 |
Ā Fruit at visit 3 (g) | 101.23 Ā± 41.63 | 98.59 Ā± 38.42 |
Ā Meat at visit 3 (g) | 104.63 Ā± 36.96 | 101.54 Ā± 34.38 |
Ā Days of participating in >30Ā min physical activity in past 7 days at visit 3 | 5.98 Ā± 1.97 | 5.83 Ā± 2.10 |
Ā Days of participating in specific exercise session in past 7 days at visit 3 | 4.17 Ā± 2.88 | 3.99 Ā± 2.87 |